US drug advisory recommends Celltrion’s Rituxan biosimilar for approval
기사승인 2018.10.11 12:10:11
Lee Han-soo corea022@docdocdoc.co.kr
- 1HospitalUS expert sees need for new treatment models for Alzheimer’s disease
- 2Policy'Big data is overrated, vulnerable to contamination'
- 3Pharma[ASCO 2019] Imfinzi 1st IO to report 3-year OS in unresectable stage III NSCLC
- 4Device/ICTJW Medical to launch Hitachi's ultrasound scanner device
- 5PeopleAtopic dermatitis patients demand reimbursement for Sanofi’s biological drug
- 6PolicyExpat workers left behind in mandatory health insurance program
- 7Bio‘MDM2 gene’ may be associated with hyperprogression after immunotherapy
set_C1
